Multicenter Placebo-Controlled Randomized Study of Ethyl Pyruvate in Horses Following Surgical Treatment for ≥ 360° Large Colon Volvulus.
colic
ethyl pyruvate
horse
large colon
survival
volvulus
Journal
Frontiers in veterinary science
ISSN: 2297-1769
Titre abrégé: Front Vet Sci
Pays: Switzerland
ID NLM: 101666658
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
02
2020
accepted:
27
03
2020
entrez:
7
5
2020
pubmed:
7
5
2020
medline:
7
5
2020
Statut:
epublish
Résumé
Identifying therapies that mitigate ischemic colonic injury and improve mucosal healing and intestinal viability are crucial to improving survival in horses with ≥360° large colon volvulus (LCV). Ethyl pyruvate is the ethyl ester of pyruvate with diverse pharmacologic effects that limit ischemic injury and hasten intestinal mucosal repair in preclinical rodents, sheep and swine models. The objective of this study was to determine the effects of ethyl pyruvate on systemic indices of colon viability, expression of inflammatory genes in whole blood, morbidity and survival after surgical correction of LCV compared to controls. Horses received either 150 mg/kg ethyl pyruvate in 1 liter lactated Ringer's solution (LRS) or 1 liter LRS intravenously (IV) every 6 h for 24 h following surgical recovery for correction of LCV. Colic duration, perioperative heart rate (HR), packed cell volume (PCV), total solids (TS), blood L-lactate concentration, surgical time, intraoperative episodes of hypoxemia and hypotension, expression of inflammatory cytokine genes, fecal consistency and survival to hospital discharge were compared between ethyl pyruvate treated horses and controls. Twenty-two horses, 12 receiving ethyl pyruvate and 10 controls, were enrolled in the study. Ethyl pyruvate was safely administered to horses following surgical correction of LCV. No significant effects of ethyl pyruvate on post-operative variables, including survival, were found. Seven of 12 ethyl pyruvate treated horses and 5/10 controls survived to hospital discharge. Higher HR, PCV and blood L-lactate concentration at the time of hospital admission,
Identifiants
pubmed: 32373640
doi: 10.3389/fvets.2020.00204
pmc: PMC7187886
doi:
Types de publication
Case Reports
Langues
eng
Pagination
204Informations de copyright
Copyright © 2020 Johnson, Holcombe, Shearer, Watson, Gandy, Southwood, Lynch, Schroeder, Fogle and Sordillo.
Références
Vet Surg. 2006 Jun;35(4):356-60
pubmed: 16756616
Ther Clin Risk Manag. 2016 Feb 23;12:287-94
pubmed: 26966369
Shock. 2003 Dec;20(6):521-8
pubmed: 14625476
Vet Immunol Immunopathol. 2011 May 15;141(1-2):92-9
pubmed: 21419499
Equine Vet J. 2013 Mar;45(2):219-23
pubmed: 22994687
Arch Surg. 2007 Feb;142(2):166-71
pubmed: 17309968
Equine Vet J. 2013 May;45(3):333-9
pubmed: 22943507
Equine Vet J. 2015 Nov;47(6):650-4
pubmed: 25257041
Vet Surg. 1988 Mar-Apr;17(2):77-81
pubmed: 3238878
Equine Vet J. 2005 Jul;37(4):296-302
pubmed: 16028616
J Cardiothorac Vasc Anesth. 2009 Jun;23(3):324-9
pubmed: 18835526
Intensive Care Med. 2003 Nov;29(11):2050-8
pubmed: 12955182
Vet Immunol Immunopathol. 2016 May;173:10-6
pubmed: 27090620
Equine Vet J. 2011 May;43(3):341-7
pubmed: 21492212
Vet Surg. 2007 Aug;36(6):563-7
pubmed: 17686130
Crit Care Med. 2001 Aug;29(8):1513-8
pubmed: 11505117
Vet Surg. 2012 Jul;41(5):582-8
pubmed: 22571759
Vet Surg. 2008 Dec;37(8):786-90
pubmed: 19121175
Equine Vet J. 2015 May;47(3):279-84
pubmed: 24735170
Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:1-5
pubmed: 25126977
J Invest Surg. 2016 Oct;29(5):260-5
pubmed: 27010523
Surg Innov. 2012 Dec;19(4):394-8
pubmed: 22298750
Shock. 2002 Jun;17(6):473-7
pubmed: 12069183
Int Immunopharmacol. 2019 Jun;71:155-163
pubmed: 30901678
Crit Care. 2013 Mar 11;17(2):R44
pubmed: 23497622